amrinone and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone

amrinone has been researched along with 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (40.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bristol, JA; Cain, MH; Weishaar, RE	1
Kasugai, S; Miyamoto, K; Ohya, K; Sawanishi, H; Suzuki, H; Suzuki, N; Takagi, K; Waki, Y; Yamamoto, S	1
Weiss, RM; Wheeler, MA	1
Chiba, S; Iwatsuki, K; Ren, LM	1
Matsumori, A; Nose, Y; Ono, K; Sasayama, S; Sato, Y; Shioi, T	1

Reviews

1 review(s) available for amrinone and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone

Article	Year
A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity. Journal of medicinal chemistry, 1985, Volume: 28, Issue:5 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Platelets; Calmodulin; Cardiotonic Agents; Guinea Pigs; Humans; Hypersensitivity; In Vitro Techniques; Lung Diseases; Myocardium; Platelet Aggregation; Substrate Specificity	1985

Article

Year

A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.

Journal of medicinal chemistry, 1985, Volume: 28, Issue:5

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Platelets; Calmodulin; Cardiotonic Agents; Guinea Pigs; Humans; Hypersensitivity; In Vitro Techniques; Lung Diseases; Myocardium; Platelet Aggregation; Substrate Specificity

1985

Other Studies

4 other study(ies) available for amrinone and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone

Article	Year
Selective inhibitors of cyclic AMP-specific phosphodiesterase: heterocycle-condensed purines. Journal of medicinal chemistry, 1997, Sep-26, Volume: 40, Issue:20 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Depression, Chemical; Heart; Isoenzymes; Male; Models, Chemical; Muscle Relaxation; Myocardium; Phosphodiesterase Inhibitors; Purines; Shrews; Trachea	1997
Insulin activation of cyclic AMP phosphodiesterase in intact ureteral segments. The Journal of pharmacology and experimental therapeutics, 1988, Volume: 247, Issue:2 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Amrinone; Animals; Cyclic GMP; Enzyme Activation; Female; Guinea Pigs; Insulin; Kinetics; Milrinone; Purinones; Pyridones; Pyrrolidinones; Rolipram; Ureter	1988
Effects of cyclic nucleotide phosphodiesterase IV inhibitor, Ro20,1724, on pancreatic exocrine secretion in dog. Clinical and experimental pharmacology & physiology, 1994, Volume: 21, Issue:9 Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Amrinone; Analysis of Variance; Animals; Bicarbonates; Cyclic AMP; Cyclic GMP; Dogs; Drug Interactions; Female; Injections, Intra-Arterial; Male; Pancreatic Juice; Phosphodiesterase Inhibitors; Proteins; Secretin; Sincalide; Trifluoperazine	1994
Differential modulation of cytokine production by drugs: implications for therapy in heart failure. Journal of molecular and cellular cardiology, 1996, Volume: 28, Issue:12 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; 8-Bromo Cyclic Adenosine Monophosphate; Amrinone; Cells, Cultured; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 5; Heart Failure; Humans; Interleukin-1; Interleukin-6; Kinetics; Leukocytes, Mononuclear; Lipopolysaccharides; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperidines; Pyrazines; Pyridazines; Quinazolines; Quinolines; Tumor Necrosis Factor-alpha	1996